The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 05, 2015

Filed:

Apr. 25, 2011
Applicants:

Kwan-su Kim, Seoul, KR;

Cheol-joo Chae, Daejeon, KR;

Jae-min Kang, Seoul, KR;

Jeong-dae Suh, Daejeon, KR;

Myung-ae Chung, Daejeon, KR;

Ki-bong Song, Daejeon, KR;

Inventors:

Kwan-Su Kim, Seoul, KR;

Cheol-Joo Chae, Daejeon, KR;

Jae-Min Kang, Seoul, KR;

Jeong-Dae Suh, Daejeon, KR;

Myung-Ae Chung, Daejeon, KR;

Ki-Bong Song, Daejeon, KR;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12Q 1/00 (2006.01); B82Y 15/00 (2011.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
B82Y 15/00 (2013.01); G01N 33/6896 (2013.01); G01N 2800/2821 (2013.01);
Abstract

A method for diagnosing Alzheimer's disease by detecting the presence of beta-amyloid in cells using a phototransistor device. Cells that potentially contain beta-amyloid are provided and labeled with a multi-protein that selectively binds to beta-amyloid if present and that includes streptavidin, biotin and polyethylene glycol connected in sequence with the streptavidin being bound to a magnetic bead and the polyethylene glycol being bound to the beta-amyloid, to provide labeled cells. A phototransistor device including a channel layer is provided and a difference in photocurrent determined corresponding to incident light measured before and after selectively fixing the labeled cells on a surface of the channel layer by applying an external magnetic field effective to attract the magnetic bead to the phototransistor device through a permanent magnet positioned below the channel. Any difference between the first and second photocurrents indicates the presence of, and optionally amount of, labeled beta-amyloid in the cells.


Find Patent Forward Citations

Loading…